Got quite close to my next buy in target.
Shall see how AUD and gold do tonight, might have to lower my buy in price further, and increase the quantity.
Looking a their historical charts it is not as though a SP pull back should surprise anybody, before the next run up. I think my next buy in if my target reached will be quite a bit larger.t
- Forums
- ASX - By Stock
- NST
- NST - Chart Analysis - 19 June 2016
NST - Chart Analysis - 19 June 2016, page-80
-
-
- There are more pages in this discussion • 136 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NST (ASX) to my watchlist
(20min delay)
|
|||||
Last
$15.80 |
Change
0.000(0.00%) |
Mkt cap ! $18.16B |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 1027 | $16.64 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$15.01 | 250 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 14374 | 15.790 |
2 | 18559 | 15.780 |
1 | 500 | 15.770 |
4 | 44514 | 15.760 |
4 | 22245 | 15.750 |
Price($) | Vol. | No. |
---|---|---|
15.830 | 2507 | 1 |
15.840 | 15445 | 2 |
15.850 | 18812 | 2 |
15.880 | 1402 | 2 |
15.890 | 12972 | 2 |
Last trade - 09.46am 10/10/2024 (20 minute delay) ? |
Featured News
LU7
The Breakdown: Lithium Universe talks refinery design and lithium processing in strong preliminary feasibility study for Bécancour
RCE
Phase II clinical trial recruitment for R327G topical gel passes halfway, showing promising results against bacterial skin infections
NST (ASX) Chart |
Day chart unavailable
The Watchlist
AHK
ARK MINES LIMITED
Ben Emery, Executive Director
Ben Emery
Executive Director
Previous Video
Next Video
SPONSORED BY The Market Online